Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $278.95 in the prior trading day, Cigna Group (NYSE: CI) closed at $276.02, down -1.05%. In other words, the price has decreased by -$1.05 from its previous closing price. On the day, 1.62 million shares were traded. CI stock price reached its highest trading level at $279.01 during the session, while it also had its lowest trading level at $270.57.
Ratios:
Our goal is to gain a better understanding of CI by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $370.
On February 06, 2025, Bernstein Downgraded its rating to Mkt Perform which previously was Outperform but kept the price unchanged to $323.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.Piper Sandler initiated its Overweight rating on June 26, 2024, with a $400 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 03 ’25 when Cordani David bought 4,134 shares for $241.88 per share. The transaction valued at 999,916 led to the insider holds 157,935 shares of the business.
Evanko Brian C sold 5,368 shares of CI for $1,610,400 on Oct 03 ’25. The insider now owns 51,182 shares after completing the transaction at $300.00 per share. On Oct 03 ’25, another insider, Evanko Brian C, who serves as the Officer of the company, bought 5,368 shares for $300.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 73732063232 and an Enterprise Value of 101073068032. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.18, and their Forward P/E ratio for the next fiscal year is 9.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 0.377 whereas that against EBITDA is 8.676.
Stock Price History:
The Beta on a monthly basis for CI is 0.28, which has changed by -0.021331072 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $350.00, while it has fallen to a 52-week low of $239.51. The 50-Day Moving Average of the stock is 1.80%, while the 200-Day Moving Average is calculated to be -7.70%.
Shares Statistics:
The stock has traded on average 1.96M shares per day over the past 3-months and 1310080 shares per day over the last 10 days, according to various share statistics. A total of 266.60M shares are outstanding, with a floating share count of 262.80M. Insiders hold about 1.62% of the company’s shares, while institutions hold 90.41% stake in the company. Shares short for CI as of 1767139200 were 4691680 with a Short Ratio of 2.40, compared to 1764288000 on 3934383. Therefore, it implies a Short% of Shares Outstanding of 4691680 and a Short% of Float of 2.33.
Dividends & Splits
In the trailing 12 months, CI’s forward annual dividend rate was 5.93, compared to 6.04 this year. Against a Trailing Annual Dividend Yield of 0.021258289. The stock’s 5-year Average Dividend Yield is 1.52. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-12-04 with an ex-dividend date of 2025-12-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
At present, 22.0 analysts are actively evaluating the performance of Cigna Group (CI) in the stock market.The consensus estimate for the next quarter is $7.24, with high estimates of $7.86 and low estimates of $6.51.
Analysts are recommending an EPS of between $29.78 and $29.53 for the fiscal current year, implying an average EPS of $29.64. EPS for the following year is $30.46, with 24.0 analysts recommending between $32.82 and $29.96.
Revenue Estimates
12 analysts predict $69.53B in revenue. The current quarter. It ranges from a high estimate of $74.72B to a low estimate of $65.32B. As of. The current estimate, Cigna Group’s year-ago sales were $65.68BFor the next quarter, 12 analysts are estimating revenue of $67.2B. There is a high estimate of $71.2B for the next quarter, whereas the lowest estimate is $64.19B.
A total of 14 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $277.15B, while the lowest revenue estimate was $253.3B, resulting in an average revenue estimate of $270.54B. In the same quarter a year ago, actual revenue was $247.1BBased on 13 analysts’ estimates, the company’s revenue will be $283.03B in the next fiscal year. The high estimate is $306.37B and the low estimate is $263.33B.
